Alphatec Holdings (NASDAQ: ATEC) and Vascular Solutions (NASDAQ:VASC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitabiliy, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Insider and Institutional Ownership

20.8% of Alphatec Holdings shares are held by institutional investors. Comparatively, 80.2% of Vascular Solutions shares are held by institutional investors. 34.9% of Alphatec Holdings shares are held by insiders. Comparatively, 6.9% of Vascular Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Alphatec Holdings has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, Vascular Solutions has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Alphatec Holdings and Vascular Solutions, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alphatec Holdings 0 0 0 0 N/A
Vascular Solutions 0 4 0 0 2.00

Vascular Solutions has a consensus price target of $55.50, suggesting a potential downside of 0.89%. Given Vascular Solutions’ higher probable upside, analysts plainly believe Vascular Solutions is more favorable than Alphatec Holdings.

Profitability

This table compares Alphatec Holdings and Vascular Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Alphatec Holdings -23.27% N/A -29.46%
Vascular Solutions 13.02% 15.78% 14.30%

Valuation & Earnings

This table compares Alphatec Holdings and Vascular Solutions’ top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Alphatec Holdings N/A N/A N/A ($3.37) -0.50
Vascular Solutions N/A N/A N/A $0.70 80.00

Alphatec Holdings is trading at a lower price-to-earnings ratio than Vascular Solutions, indicating that it is currently the more affordable of the two stocks.

Summary

Vascular Solutions beats Alphatec Holdings on 6 of the 8 factors compared between the two stocks.

Alphatec Holdings Company Profile

Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.

Vascular Solutions Company Profile

Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company’s product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company’s product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.